Home Carboxys Trans-4-(Maleimidomethyl)cyclohexanecarboxylic Acid-NHS

Trans-4-(Maleimidomethyl)cyclohexanecarboxylic Acid-NHS

CAS No.:
71875-81-5
Catalog Number:
AG003U9Y
Molecular Formula:
C16H18N2O6
Molecular Weight:
334.3239
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003U9Y
Chemical Name:
Trans-4-(Maleimidomethyl)cyclohexanecarboxylic Acid-NHS
CAS Number:
71875-81-5
Molecular Formula:
C16H18N2O6
Molecular Weight:
334.3239
MDL Number:
MFCD08274640
IUPAC Name:
(2,5-dioxopyrrolidin-1-yl) 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexane-1-carboxylate
InChI:
InChI=1S/C16H18N2O6/c19-12-5-6-13(20)17(12)9-10-1-3-11(4-2-10)16(23)24-18-14(21)7-8-15(18)22/h5-6,10-11H,1-4,7-9H2
InChI Key:
JJAHTWIKCUJRDK-UHFFFAOYSA-N
SMILES:
O=C([C@@H]1CC[C@H](CC1)CN1C(=O)C=CC1=O)ON1C(=O)CCC1=O
EC Number:
613-734-7
UNII:
B357P1G1IF
NSC Number:
344483
Properties
Complexity:
599  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
334.116g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
334.328g/mol
Monoisotopic Mass:
334.116g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
101A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.1  
Literature
Title Journal
Enhanced extravasation, stability and in vivo cardiac gene silencing via in situ siRNA-albumin conjugation. Molecular pharmaceutics 20120101
A novel pathway for maytansinoid release from thioether linked antibody-drug conjugates (ADCs) under oxidative conditions. Chemical communications (Cambridge, England) 20111014
Antibody-maytansinoid conjugates designed to bypass multidrug resistance. Cancer research 20100315
In vitro characterization of ligand-induced oligomerization of the S. cerevisiae G-protein coupled receptor, Ste2p. Biochimica et biophysica acta 20090101
The design and evaluation of a novel targeted drug delivery system using cationic emulsion-antibody conjugates. Journal of controlled release : official journal of the Controlled Release Society 20051128
Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense & nucleic acid drug development 20020401
Effect of peptide-carrier coupling on peptide-specific immune responses. Immunobiology 20010501
Homogeneous enzyme immunoassay for triiodothyronine in serum. Clinical chemistry 20010301
A robust method for the preparation and purification of antibody/streptavidin conjugates. Bioconjugate chemistry 20010101
Properties